Clinical trial transplants hepatitis C-infected kidneys into non-infected patients

Predicting Multiple Sclerosis Risk for Relatives with More Ease
September 26, 2016
Multiple sclerosis risk may increase with obesity in children and teens
September 27, 2016
Show all

Clinical trial transplants hepatitis C-infected kidneys into non-infected patients

Kidney transplants are now possible with donated kidneys infected with hepatitis C.

The first patient to receive a kidney transplant as part of a trial that matches kidneys from donors who had the Hepatitis C virus (HCV) with recipients without the virus has no evidence of HCV in her blood. Irma Hendricks of East Stroudsburg, PA received a kidney transplant in July 2016, and was treated with a full regimen of Zepatier—a recently-approved oral medication prescribed to eradicate HCV.

The clinical trial, known as THINKER, led by David S. Goldberg, MD, MSCE, and Peter Reese, MD, MSCE, both assistant professors of Medicine and Epidemiology at Penn Medicine, aims to determine the safety and efficacy of transplanting kidneys from Hepatitis C-positive donors into patients currently on the kidney transplant waitlist who do not have the Hepatitis C virus.

Read Full Article: Clinical trial transplants hepatitis C-infected kidneys into non-infected patients – Nephrology News & Issues

Read Full Article: Clinical trial transplants hepatitis C-infected kidneys into non-infected patients – Nephrology News & Issues

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.